Medicare Enrolled
Dr. Kenneth Cerreta, M.D.
Pulmonary Disease · Clearwater, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cerreta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cerreta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cerreta
Dr. Kenneth Cerreta is a pulmonary disease specialist in Clearwater, FL, with 15 years of NPI registration. Based on federal Medicare data, Dr. Cerreta performed 1,523 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Cerreta received a total of $5,361 from 42 pharmaceutical and/or device companies across 268 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cerreta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 41% volume in FL
$5,361 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 131027 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗1,523
Medicare services
Top 41% in FL for pulmonary disease
Not available
Unique patients (not deduplicated)
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
329 | $94 | $283 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
291 | $170 | $533 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
200 | $90 | $161 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
132 | $63 | $182 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
122 | $33 | $79 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
99 | $136 | $429 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
95 | $39 | $90 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
81 | $21 | $76 |
| New patient office visit, complex (60-74 min) | 44 | $151 | $309 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
41 | $20 | $55 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
39 | $119 | $215 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
20 | $9 | $30 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
15 | $26 | $68 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
15 | $61 | $198 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$5,361
Total received (2018-2024)
Avg $766/year across 7 years
Top 35% in FL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
268
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,998
2023
$875
2022
$517
2021
$120
2020
$505
2019
$911
2018
$436
Payments by company (2024)
GlaxoSmithKline, LLC.
$280
Bayer Healthcare Pharmaceuticals Inc.
$260
Inari Medical, Inc.
$191
AstraZeneca Pharmaceuticals LP
$186
Insmed, Inc.
$169
Actelion Pharmaceuticals US, Inc.
$143
United Therapeutics Corporation
$118
ABBVIE INC.
$84
Merck Sharp & Dohme LLC
$83
Amgen Inc.
$82
HARMONY BIOSCIENCES LLC
$77
Regeneron Healthcare Solutions, Inc.
$68
Grifols USA, LLC
$54
Inspire Medical Systems, Inc.
$49
Shionogi Inc
$38
Takeda Pharmaceuticals U.S.A., Inc.
$32
Avadel CNS Pharmaceuticals, LLC
$30
GENZYME CORPORATION
$24
Electromed, Inc.
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 36.6% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$967
AstraZeneca Pharmaceuticals LP
$572
Bayer Healthcare Pharmaceuticals Inc.
$460
Insmed, Inc.
$424
Actelion Pharmaceuticals US, Inc.
$310
Boehringer Ingelheim Pharmaceuticals, Inc.
$270
Bayer HealthCare Pharmaceuticals Inc.
$211
Inari Medical, Inc.
$191
Regeneron Healthcare Solutions, Inc.
$159
United Therapeutics Corporation
$149
Amgen Inc.
$147
Electromed, Inc.
$128
E.R. Squibb & Sons, L.L.C.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$116
Allergan Inc.
$91
ABBVIE INC.
$84
Vapotherm Inc
$84
Merck Sharp & Dohme LLC
$83
HARMONY BIOSCIENCES LLC
$77
Inspire Medical Systems, Inc.
$77
Harmony Biosciences LLC
$70
Shionogi Inc
$62
Mylan Specialty L.P.
$61
Genentech USA, Inc.
$54
Grifols USA, LLC
$54
Novartis Pharmaceuticals Corporation
$41
Avadel CNS Pharmaceuticals, LLC
$30
Janssen Pharmaceuticals, Inc
$29
Circassia Pharmaceuticals Inc
$27
PFIZER INC.
$25
GENZYME CORPORATION
$24
Philips Electronics North America Corporation
$18
Theravance Biopharma, Inc.
$17
CSL Behring
$16
PORTOLA PHARMACEUTICALS, INC.
$16
Inogen, Inc.
$16
Shire North American Group Inc
$13
ADVANCED RESPIRATORY, INC
$13
Teva Pharmaceuticals USA, Inc.
$13
Allergan, Inc.
$13
JAZZ PHARMACEUTICALS INC.
$12
Nabriva Therapeutics, plc
$11
Top 3 companies account for 37.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · CINQAIR · CT THROMBECTOMY SYSTEM KIT · DUPIXENT · Esbriet · FASENRA · FLOWTRIEVER CATHETER · Fetroja · GLASSIA · INSPIRE · InogenOne · Kcentra · LOKELMA · LUMRYZ · NUCALA · OFEV · OPDIVO · OPSUMIT · PREVNAR - 13 · Prolastin-C Liquid · S · SMARTVEST · SPIRIVA · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TAVNEOS · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · VAPOTHERM · VIBATIV · WAKIX · WINREVAIR · Wakix · XARELTO · XOLAIR · Xenleta · Xolair · Yupelri
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
89
County median income
$70,293
Nearest hospital to ZIP centroid (approximate)
MORTON PLANT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cerreta is a clinical cardiology specialist, with moderate Medicare volume, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cerreta experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Cerreta performed 329 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Cerreta receive payments from pharmaceutical companies?
Yes. Dr. Cerreta received a total of $5,361 from 42 companies across 268 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cerreta's costs compare to other pulmonary diseases in Clearwater?
Dr. Cerreta's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cerreta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Clearwater
Browse pulmonary diseases in Clearwater ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in FL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in FL
Which FL pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Bayer Healthcare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer Healthcare Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology